Related Experiment Video
Updated: Aug 11, 2026

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells
Published on: March 1, 2024
Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome
Tetsuya Niihori1, Yoko Aoki, Yoko Narumi
1Department of Medical Genetics, Tohoku University School of Medicine, Sendai, Japan.
Insights
Cardio-facio-cutaneous (CFC) syndrome shares features with Noonan and Costello syndromes. Genetic analysis revealed KRAS and BRAF mutations in CFC patients, implicating the RAS-RAF-ERK pathway in these related disorders.
Area of Science:
- Genetics
- Molecular Biology
- Developmental Biology
Background:
- Cardio-facio-cutaneous (CFC) syndrome presents with characteristic facial features, cardiac anomalies, and intellectual disability.
- CFC syndrome exhibits phenotypic overlap with Noonan syndrome and Costello syndrome.
- Noonan and Costello syndromes are linked to mutations in PTPN11 and HRAS genes, respectively.
Purpose of the Study:
- To investigate the genetic underpinnings of Cardio-facio-cutaneous (CFC) syndrome.
- To explore the molecular relationship between CFC, Noonan, and Costello syndromes.
Main Methods:
- Genetic analysis of 43 individuals diagnosed with CFC syndrome.
- Identification and sequencing of mutations in key genes within the RAS-RAF-ERK pathway.
Main Results:
- Two heterozygous KRAS mutations were identified in three individuals with CFC syndrome.
- Eight BRAF mutations were found in 16 individuals with CFC syndrome.
- These findings suggest a significant role for KRAS and BRAF mutations in CFC syndrome.
Conclusions:
- Dysregulation of the RAS-RAF-ERK signaling pathway is a common molecular mechanism underlying CFC, Noonan, and Costello syndromes.
- Identifying mutations in KRAS and BRAF provides crucial insights into the pathogenesis of CFC syndrome.
Abstract:
Cardio-facio-cutaneous (CFC) syndrome is characterized by a distinctive facial appearance, heart defects and mental retardation. It phenotypically overlaps with Noonan and Costello syndrome, which are caused by mutations in PTPN11 and HRAS, respectively. In 43 individuals with CFC, we identified two heterozygous KRAS mutations in three individuals and eight BRAF mutations in 16 individuals, suggesting that dysregulation of the RAS-RAF-ERK pathway is a common molecular basis for the three related disorders.
Related Concept Videos
The Ras Gene
Ras is a superfamily...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Abnormal Proliferation
MAPK Signaling Cascades
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

